Max Healthcare (Max Institute of Cancer Care)
One of north India's largest private hospital groups, with a network of cancer units, a standalone cancer centre in Delhi and a large share of India's private-sector oncology trials.
Overview
Max Healthcare opened its first centre in Panchsheel Park, Delhi, in 2000 and as of June 2025 operated 22 hospitals with more than 5,000 beds, mainly in north India; it is listed on the BSE and NSE and is a NIFTY 50 constituent. A standalone Max Cancer Centre was commissioned in Lajpat Nagar, Delhi, in 2016, and the group's oncology programme (marketed as the Max Institute of Cancer Care) spans surgical, medical, radiation and haemato-oncology, bone marrow transplant, robotic surgery and precision oncology across its network. Max is a frequent site for international registration trials in India.
- Cancer centre network
- Bone marrow transplant
- Robotic surgery
- Industry clinical trials
Pages like this
not linked directly; found by shared links- InstitutionRajiv Gandhi Cancer Institute and Research Centre
Shares Robotic & minimally invasive surgery, Comprehensive genomic profiling, Diffuse large B-cell lymphoma, Head and neck squamous cell carcinoma.
- InstitutionApollo Hospitals (Apollo Cancer Centres)
Shares Robotic & minimally invasive surgery, Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- InstitutionIstanbul University Institute of Oncology
Shares Comprehensive genomic profiling, Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- InstitutionChang Gung Memorial Hospital
Shares Robotic & minimally invasive surgery, Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- InstitutionHealthCare Global Enterprises
Shares Comprehensive genomic profiling, Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- InstitutionSiriraj Hospital, Mahidol University
Shares Robotic & minimally invasive surgery, Head and neck squamous cell carcinoma, CAR-T cell therapy, HR-positive / HER2-negative breast cancer.
- CompanyInivata
Shares Comprehensive genomic profiling, Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- PersonCharu Aggarwal
Shares Comprehensive genomic profiling, Head and neck squamous cell carcinoma, Non-small-cell lung cancer.